Today, Rep. Doris Matsui (D-CA) and Sen. Peter Welch (D-VT) introduced the 340B PATIENTS Act, which would prohibit drug manufacturers from putting restrictions on covered entities and contract pharmacies that participate in the 340B Drug Pricing Program.
"ASHP strongly supports the 340B PATIENTS ACT, which will ensure pharmaceutical manufacturers honor their obligations to covered entities and contract pharmacies under the 340B Drug Pricing Program," said Tom Kraus, ASHP’s vice president of government relations.
The legislation is cosponsored in the Senate by Sen. Jeff Merkley (D-OR) and in the House by Reps. Lori Trahan (D-MA), Paul Tonko (D-NY), Sharice Davids (D-KS), Betty McCollum (D-MN), Shri Thanedar (D-MI), Rashida Tlaib (D-MI), Maxwell Frost (D-FL), and Kathy Castor (D-FL).
